Figure 1From: Cancer risk in MLH1, MSH2 and MSH6 mutation carriers; different risk profiles may influence clinical management All Lynch associated cancers (colorectal, endometrial, stomach, ovaries, upper uroepithelial tract, biliary tract, skin and brain cancer): cumulative risks for MLH1, MSH2 and MSH6 mutation carriers.Back to article page